+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
FEMALE
ID07832279

Comparing 1-Week and 3-Week Partial Breast Irradiation Using IMRT After Breast-Conserving Surgery in Women with Low-Risk Early-Stage Breast Cancer

Led by Fudan University · Updated on 2026-09-25

818

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two different schedules of partial breast irradiation PBI using intensity-modulated radiation therapy IMRT in women with low-risk early-stage breast cancer who have undergone breast-conserving surgery. This phase 3, randomized trial aims to determine if a shorter one-week radiation regimen is not inferior to the standard three-week regimen in terms of cosmetic outcomes. Participants are assigned to receive either a one-week PBI schedule delivering 26 Gy in 5 fractions once daily or a three-week PBI schedule delivering 40.05 Gy in 15 fractions once daily. Both radiation treatments target the breast tissue post-surgery. The study compares these two regimens directly to assess cosmetic results and other outcomes. During the trial, participants undergo radiation therapy according to their assigned regimen and have follow-up visits to monitor outcomes. Researchers will assess cosmetic results after three years and track locoregional cancer recurrence and overall survival over five years. Participants will also be monitored for any adverse effects related to the treatments and will continue follow-up for up to eight years from study start.

CONDITIONS

Brief Title

1-Week Versus 3-Week PBI

Research Team

J

Jinli Ma

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here